IP
BLUE

Intellectus Partners’s bluebird bio BLUE Stock Holding History

Intellectus Partners’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4
Closed -$7K – 285
2018
Q3 		$7K Hold
4
– – ﹤0.01% 501
2018
Q2 		$8K Hold
4
– – ﹤0.01% 491
2018
Q1 		$9K Hold
4
– – ﹤0.01% 480
2017
Q4 		$9K Hold
4
– – ﹤0.01% 490
2017
Q3 		$7K Sell
4
-4
-50% -$5.59K ﹤0.01% 649
2017
Q2 		$11K Sell
8
-3
-27% -$3.62K 0.01% 574
2017
Q1 		$13K Hold
11
– – 0.01% 510
2016
Q4 		$9K Buy
+11
New +$8.73K ﹤0.01% 532

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Intellectus Partners's BLUE Position: Q4 2018 in Review

Intellectus Partners sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 4 shares — an estimated $7K sold.

Intellectus Partners first reported a position in BLUE in Q4 2016 and held it in 8 quarters. The position peaked at $13K in Q1 2017. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

  • Intellectus Partners reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
  • Intellectus Partners sold 4 bluebird bio shares in Q4 2018, an estimated $7K.
  • Intellectus Partners first reported a position in bluebird bio in Q4 2016 and held it in 8 quarters.
  • Intellectus Partners's bluebird bio position peaked at $13K in Q1 2017.
  • 251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Intellectus Partners's 13F filing for Q4 2018, filed 14 Feb 2019.